METRO HEALTHCARE BERHAD

KLSE: 0329 (METRO)

最近更新时间: 5天之前, 8:57AM

0.215

-0.01 (-2.27%)

前收盘价格 0.220
收盘价格 0.220
成交量 1,543,700
平均成交量 (3个月) 5,201,496
市值 210,464,576
市盈率 (P/E TTM) 21.50
预期市盈率 (P/E Forward) 0.200
价格/销量 (P/S) 3.72
股市价格/股市净资产 (P/B) 5.54
52周波幅
0.200 (-6%) — 0.630 (193%)

市场趋势

短期 中期
行业 Medical Care Facilities (MY) 混合的 混合的
Medical Care Facilities (全球的) 混合的 混合的
股票 METRO - -

AIStockmoo 评分

1.2
分析师共识 0.0
内部交易活动 3.5
价格波动 3.0
技术平均移动指标 1.5
技术振荡指标 -2.0
平均 1.20

相关股票

股票 市值 DY P/E(TTM) P/B
METRO 210 M - 21.50 5.54
ALPHA 2 B 2.84% 33.50 9.33
DCHCARE 169 M - - 3.20
TOPVISN - 2.58% - 2.40
IHH 64 B 1.38% 24.10 2.19
KPJ 10 B 1.74% 34.00 4.13

Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia.

部门 Healthcare
行业 Medical Care Facilities
投资方式 Small Growth

该时间范围内无数据。

名称 平均购买 ($) 平均卖出 ($) 总净额 总净值 ($)
DR TAY SWI PENG @ TEE SWI PENG 0.215 - 540,000 116,600
累积净数量 540,000
累积净值 ($) 116,600
累积平均购买 ($) 0.215
累积平均卖出 ($) -
名称 持有人 日期 类型 数量 价格 价值 ($)
DR TAY SWI PENG @ TEE SWI PENG 董事 19 Dec 2024 获得 (+) 160,000 0.220 35,200
DR TAY SWI PENG @ TEE SWI PENG 大股东 19 Dec 2024 获得 (+) 160,000 0.220 35,200
DR TAY SWI PENG @ TEE SWI PENG 董事 17 Dec 2024 获得 (+) 110,000 0.210 23,100
DR TAY SWI PENG @ TEE SWI PENG 大股东 17 Dec 2024 获得 (+) 110,000 0.210 23,100
日期 类型 细节
17 Dec 2024 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
17 Dec 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
17 Dec 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
16 Dec 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - MR LIM WAI KHONG
16 Dec 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
10 Dec 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
09 Dec 2024 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
09 Dec 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
09 Dec 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
05 Dec 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - MR LIM WAI KHONG
05 Dec 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
03 Dec 2024 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
03 Dec 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
03 Dec 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
02 Dec 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - MR LIM WAI KHONG
02 Dec 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
29 Nov 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
29 Nov 2024 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
29 Nov 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR TAY SWI PENG @ TEE SWI PENG
22 Nov 2024 公告 Quarterly rpt on consolidated results for the financial period ended 30/09/2024
19 Nov 2024 TheEdge IPO Watch: IPOs aplenty with four companies to debut on Bursa
15 Nov 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - CIK ROSE ZILAWATI BINTI MOHAMED ARIFIN
15 Nov 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - DR YEE MENG KHEONG
15 Nov 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - MR LIM WAI KHONG
15 Nov 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - MISS CHUA LENG LEEK
15 Nov 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - MR SEAH CHEONG WEI
15 Nov 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
14 Nov 2024 公告 METRO HEALTHCARE BERHAD ("METRO") TRANSFER OF LISTING FROM THE LEAP MARKET OF BURSA MALAYSIA SECURITIES BERHAD (BURSA SECURITIES) TO THE ACE MARKET OF BURSA SECURITIES (TRANSFER OF LISTING)
14 Nov 2024 公告 Initial Public Offering
07 Nov 2024 公告 METRO HEALTHCARE BERHAD ("METRO") INITIAL PUBLIC OFFERING ("IPO") OF METRO IN CONJUNCTION WITH THE TRANSFER OF LISTING OF METRO FROM THE LEAP MARKET OF BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") TO THE ACE MARKET OF BURSA SECURITIES ("TRANSFER OF LISTING")
24 Oct 2024 公告 Timetable for IPO
24 Oct 2024 公告 INITIAL PUBLIC OFFERING IN CONJUNCTION WITH THE TRANSFER OF LISTING OF METRO HEALTHCARE BERHAD ("METRO" OR "COMPANY") FROM THE LEAP MARKET OF BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") TO THE ACE MARKET OF BURSA SECURITIES COMPRISING PUBLIC ISSUE OF 156,625,000 NEW ORDINARY SHARES IN METRO ("SHARES") IN THE FOLLOWING MANNER: (I) 24,472,600 NEW SHARES MADE AVAILABLE FOR APPLICATION BY THE MALAYSIAN PUBLIC; (II) 9,789,200 NEW SHARES MADE AVAILABLE FOR APPLICATION BY THE ELIGIBLE DIRECTO
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2024 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票